I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Advanced Therapy
Medicinal Products by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 2: World Historic Review for Advanced Therapy Medicinal
Products by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 3: World 15-Year Perspective for Advanced Therapy
Medicinal Products by Geographic Region - Percentage Breakdown
of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets for Years 2012, 2020 &
2027

Table 4: World Current & Future Analysis for Cell Therapy by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 5: World Historic Review for Cell Therapy by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR

Table 6: World 15-Year Perspective for Cell Therapy by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 7: World Current & Future Analysis for Tissue Engineered
Product by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR

Table 8: World Historic Review for Tissue Engineered Product by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 9: World 15-Year Perspective for Tissue Engineered
Product by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2012, 2020 & 2027

Table 10: World Current & Future Analysis for Gene Therapy by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 11: World Historic Review for Gene Therapy by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR

Table 12: World 15-Year Perspective for Gene Therapy by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 13: World Current & Future Analysis for CAR-T Therapy by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 14: World Historic Review for CAR-T Therapy by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR

Table 15: World 15-Year Perspective for CAR-T Therapy by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES
Table 16: USA Current & Future Analysis for Advanced Therapy
Medicinal Products by Type - Cell Therapy, Tissue Engineered
Product, Gene Therapy and CAR-T Therapy - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027
and % CAGR

Table 17: USA Historic Review for Advanced Therapy Medicinal
Products by Type - Cell Therapy, Tissue Engineered Product,
Gene Therapy and CAR-T Therapy Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 18: USA 15-Year Perspective for Advanced Therapy
Medicinal Products by Type - Percentage Breakdown of Value
Sales for Cell Therapy, Tissue Engineered Product, Gene Therapy
and CAR-T Therapy for the Years 2012, 2020 & 2027

CANADA
Table 19: Canada Current & Future Analysis for Advanced Therapy
Medicinal Products by Type - Cell Therapy, Tissue Engineered
Product, Gene Therapy and CAR-T Therapy - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027
and % CAGR

Table 20: Canada Historic Review for Advanced Therapy Medicinal
Products by Type - Cell Therapy, Tissue Engineered Product,
Gene Therapy and CAR-T Therapy Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 21: Canada 15-Year Perspective for Advanced Therapy
Medicinal Products by Type - Percentage Breakdown of Value
Sales for Cell Therapy, Tissue Engineered Product, Gene Therapy
and CAR-T Therapy for the Years 2012, 2020 & 2027

JAPAN
Table 22: Japan Current & Future Analysis for Advanced Therapy
Medicinal Products by Type - Cell Therapy, Tissue Engineered
Product, Gene Therapy and CAR-T Therapy - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027
and % CAGR

Table 23: Japan Historic Review for Advanced Therapy Medicinal
Products by Type - Cell Therapy, Tissue Engineered Product,
Gene Therapy and CAR-T Therapy Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 24: Japan 15-Year Perspective for Advanced Therapy
Medicinal Products by Type - Percentage Breakdown of Value
Sales for Cell Therapy, Tissue Engineered Product, Gene Therapy
and CAR-T Therapy for the Years 2012, 2020 & 2027

CHINA
Table 25: China Current & Future Analysis for Advanced Therapy
Medicinal Products by Type - Cell Therapy, Tissue Engineered
Product, Gene Therapy and CAR-T Therapy - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027
and % CAGR

Table 26: China Historic Review for Advanced Therapy Medicinal
Products by Type - Cell Therapy, Tissue Engineered Product,
Gene Therapy and CAR-T Therapy Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 27: China 15-Year Perspective for Advanced Therapy
Medicinal Products by Type - Percentage Breakdown of Value
Sales for Cell Therapy, Tissue Engineered Product, Gene Therapy
and CAR-T Therapy for the Years 2012, 2020 & 2027

EUROPE
Table 28: Europe Current & Future Analysis for Advanced Therapy
Medicinal Products by Geographic Region - France, Germany,
Italy, UK and Rest of Europe Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2020 through 2027 and %
CAGR

Table 29: Europe Historic Review for Advanced Therapy Medicinal
Products by Geographic Region - France, Germany, Italy, UK and
Rest of Europe Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019 and % CAGR

Table 30: Europe 15-Year Perspective for Advanced Therapy
Medicinal Products by Geographic Region - Percentage Breakdown
of Value Sales for France, Germany, Italy, UK and Rest of
Europe Markets for Years 2012, 2020 & 2027

Table 31: Europe Current & Future Analysis for Advanced Therapy
Medicinal Products by Type - Cell Therapy, Tissue Engineered
Product, Gene Therapy and CAR-T Therapy - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027
and % CAGR

Table 32: Europe Historic Review for Advanced Therapy Medicinal
Products by Type - Cell Therapy, Tissue Engineered Product,
Gene Therapy and CAR-T Therapy Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 33: Europe 15-Year Perspective for Advanced Therapy
Medicinal Products by Type - Percentage Breakdown of Value
Sales for Cell Therapy, Tissue Engineered Product, Gene Therapy
and CAR-T Therapy for the Years 2012, 2020 & 2027

FRANCE
Table 34: France Current & Future Analysis for Advanced Therapy
Medicinal Products by Type - Cell Therapy, Tissue Engineered
Product, Gene Therapy and CAR-T Therapy - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027
and % CAGR

Table 35: France Historic Review for Advanced Therapy Medicinal
Products by Type - Cell Therapy, Tissue Engineered Product,
Gene Therapy and CAR-T Therapy Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 36: France 15-Year Perspective for Advanced Therapy
Medicinal Products by Type - Percentage Breakdown of Value
Sales for Cell Therapy, Tissue Engineered Product, Gene Therapy
and CAR-T Therapy for the Years 2012, 2020 & 2027

GERMANY
Table 37: Germany Current & Future Analysis for Advanced
Therapy Medicinal Products by Type - Cell Therapy, Tissue
Engineered Product, Gene Therapy and CAR-T Therapy -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 38: Germany Historic Review for Advanced Therapy
Medicinal Products by Type - Cell Therapy, Tissue Engineered
Product, Gene Therapy and CAR-T Therapy Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 39: Germany 15-Year Perspective for Advanced Therapy
Medicinal Products by Type - Percentage Breakdown of Value
Sales for Cell Therapy, Tissue Engineered Product, Gene Therapy
and CAR-T Therapy for the Years 2012, 2020 & 2027

ITALY
Table 40: Italy Current & Future Analysis for Advanced Therapy
Medicinal Products by Type - Cell Therapy, Tissue Engineered
Product, Gene Therapy and CAR-T Therapy - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027
and % CAGR

Table 41: Italy Historic Review for Advanced Therapy Medicinal
Products by Type - Cell Therapy, Tissue Engineered Product,
Gene Therapy and CAR-T Therapy Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 42: Italy 15-Year Perspective for Advanced Therapy
Medicinal Products by Type - Percentage Breakdown of Value
Sales for Cell Therapy, Tissue Engineered Product, Gene Therapy
and CAR-T Therapy for the Years 2012, 2020 & 2027

UNITED KINGDOM
Table 43: UK Current & Future Analysis for Advanced Therapy
Medicinal Products by Type - Cell Therapy, Tissue Engineered
Product, Gene Therapy and CAR-T Therapy - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027
and % CAGR

Table 44: UK Historic Review for Advanced Therapy Medicinal
Products by Type - Cell Therapy, Tissue Engineered Product,
Gene Therapy and CAR-T Therapy Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 45: UK 15-Year Perspective for Advanced Therapy Medicinal
Products by Type - Percentage Breakdown of Value Sales for Cell
Therapy, Tissue Engineered Product, Gene Therapy and CAR-T
Therapy for the Years 2012, 2020 & 2027

REST OF EUROPE
Table 46: Rest of Europe Current & Future Analysis for Advanced
Therapy Medicinal Products by Type - Cell Therapy, Tissue
Engineered Product, Gene Therapy and CAR-T Therapy -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 47: Rest of Europe Historic Review for Advanced Therapy
Medicinal Products by Type - Cell Therapy, Tissue Engineered
Product, Gene Therapy and CAR-T Therapy Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 48: Rest of Europe 15-Year Perspective for Advanced
Therapy Medicinal Products by Type - Percentage Breakdown of
Value Sales for Cell Therapy, Tissue Engineered Product, Gene
Therapy and CAR-T Therapy for the Years 2012, 2020 & 2027

ASIA-PACIFIC
Table 49: Asia-Pacific Current & Future Analysis for Advanced
Therapy Medicinal Products by Type - Cell Therapy, Tissue
Engineered Product, Gene Therapy and CAR-T Therapy -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 50: Asia-Pacific Historic Review for Advanced Therapy
Medicinal Products by Type - Cell Therapy, Tissue Engineered
Product, Gene Therapy and CAR-T Therapy Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 51: Asia-Pacific 15-Year Perspective for Advanced Therapy
Medicinal Products by Type - Percentage Breakdown of Value
Sales for Cell Therapy, Tissue Engineered Product, Gene Therapy
and CAR-T Therapy for the Years 2012, 2020 & 2027

REST OF WORLD
Table 52: Rest of World Current & Future Analysis for Advanced
Therapy Medicinal Products by Type - Cell Therapy, Tissue
Engineered Product, Gene Therapy and CAR-T Therapy -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 53: Rest of World Historic Review for Advanced Therapy
Medicinal Products by Type - Cell Therapy, Tissue Engineered
Product, Gene Therapy and CAR-T Therapy Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 54: Rest of World 15-Year Perspective for Advanced
Therapy Medicinal Products by Type - Percentage Breakdown of
Value Sales for Cell Therapy, Tissue Engineered Product, Gene
Therapy and CAR-T Therapy for the Years 2012, 2020 & 2027

IV. COMPETITION
Total Companies Profiled: 36